bioRxiv · 10.1101/2023.08.11.552994
Age-linked lung pathology is reduced by immunotherapeutic targeting of isoDGR protein damage
Abstract
Advancing age is the primary risk factor for pulmonary diseases. Our investigation revealed an 8-fold increase in aging induced isoDGR-damaged proteins in lung tissue from human pulmonary fibrosis patients compared to healthy tissues, accompanied by elevated frequencies of CD68+/CD11b+ macrophages, indicating lung tissue is susceptible to time-dependent accumulation of isoDGR-proteins. To elucidate the mechanisms through which isoDGR-proteins may exacerbate aging lung disorders for potential therapeutic targeting, we assessed the functional role of this isoDGR-motif in naturally-aged mice and mice lacking the corresponding isoDGR repair enzyme (Pcmt1-/-). IsoDGR-protein accumulation in mouse lung tissue and blood vessels correlated with chronic low-grade inflammation, pulmonary edema, and hypoxemia. IsoDGR accretion induced mitochondrial and ribosomal dysfunctions, cellular senescence, and apoptosis, contributing to progressive lung damage over time. Treatment with anti-isoDGR antibodies suppressed TLR pathway activity, mitigated cytokine-driven inflammation, restored mtDNA expression, and significantly reduced lung pathology in-vivo. Similarly, exposure of lung endothelial cells to isoDGR-modified fibronectin impaired oxygen consumption, increased reactive oxygen species levels, and disrupted acidification, but these effects were efficiently reversed by target-specific antibody therapy. Collectively, our findings underscore the significant contribution of isoDGR-damaged proteins to age-linked lung pathology. IsoDGR-specific therapy emerges as a promising treatment approach for pulmonary disorders in older patients.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Kalailingam, P., Mohd-Kahliab, K.-H., SoFong Cam Ngan, S. C. N., Iyappan, R., Lee, B. S. T., Bhargy Sharma, B. S., Machan, R., Bo, S. T., Chambers, E. S., Fajardo, V. A., Macpherson, R. E. K., Liu, J., Klentrou, P., Tsiani, E. L., Lim, K. L., Su, I. H., Gao, Y.-G., Richard, A. M., Kalaria, R. N., Chen, C. P., McCarthy, N. E., Sze, S. K.. 2023-08-14. Age-linked lung pathology is reduced by immunotherapeutic targeting of isoDGR protein damage. https://doi.org/10.1101/2023.08.11.552994
Cite the original work for its findings. Save a collection to share your selection of sources.